NCT03659812

Brief Summary

The aim of this study is to analyse the efficacy of MACS technique for the selection of spermatozoa and its effects on implantation, pregnancy and miscarriage rate. This study will be performed by two IVI clinics (IVI Sevilla and IVI Madrid) with the purpose of finding new techniques that allow us to better select spermatozoa and improve the results of assisted reproduction techniques.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
130

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 7, 2017

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 16, 2018

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 13, 2018

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

April 24, 2018

Completed
5 months until next milestone

First Posted

Study publicly available on registry

September 6, 2018

Completed
Last Updated

September 6, 2018

Status Verified

September 1, 2018

Enrollment Period

3 months

First QC Date

April 24, 2018

Last Update Submit

September 5, 2018

Conditions

Keywords

Magnetic activated cell sorting (MACS)Artificial insemination with donor sperm (AID)SpermatozoaSperm

Outcome Measures

Primary Outcomes (3)

  • Pregnancy rate

    The number of pregnancies confirmed by ultrasound divided by the number of artificial insemination cycles. Pregnancy is confirmed by ultrasound examination.

    Ultrasound examination is performed 5 weeks after artificial insemination. Pregnancy rate is calculated during the phase of data analysis.

  • Implantation rate

    The number of positive results of beta human chorionic gonadotropin (hCG) test divided by the number of artificial insemination cycles. Implantation is confirmed through the analysis of beta hCG in blood.

    The beta hCG analysis is performed 15 days after artificial insemination. Implantation rate is calculated during the phase of data analysis.

  • Live birth rate

    The number of live births divided by the number of artificial insemination cycles

    Live births are assessed at delivery (end of pregnancy period). Live birth rate is calculated during the phase of data analysis

Secondary Outcomes (5)

  • Sperm cell concentration

    This parameter is assessed when preparing the sample for artificial insemination (one hour before artificial insemination).

  • Sperm cell motility

    This parameter is assessed when preparing the sample for artificial insemination (one hour before artificial insemination).

  • Sperm cell morphology

    This parameter is assessed when preparing the sample for artificial insemination (one hour before artificial insemination).

  • Sperm cells vitality

    This parameter is assessed when preparing the sample for artificial insemination (one hour before artificial insemination).

  • Sperm sample volume

    This parameter is assessed when preparing the sample for artificial insemination (one hour before artificial insemination).

Study Arms (2)

MACS is applied to the sperm sample

EXPERIMENTAL

Previous to the AID technique, the sperm sample undergoes capacitation through Percoll density gradient and MACS

Other: MACS technique

MACS is not applied to the sperm sample

NO INTERVENTION

Previous to the AID technique, MACS only undergoes capacitation through Percoll density gradient, but not MACS technique

Interventions

MACS is a technique that allow us to tag and detect apoptotic spermatozoa. These apoptotic spermatozoa have phosphatidylserine in their membranes, so we add magnetic beads with Annexin V, which binds specifically to phosphatidylserine. The spermatozoa are then tagged and can be retained in a magnetic field, allowing us to collect just the non-apoptotic spermatozoa.

MACS is applied to the sperm sample

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Women who undergo artificial insemination with donor sperm
  • Signing an informed consent form to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IVI Sevilla

Seville, 41011, Spain

Location

MeSH Terms

Conditions

Infertility

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 24, 2018

First Posted

September 6, 2018

Study Start

November 7, 2017

Primary Completion

February 16, 2018

Study Completion

April 13, 2018

Last Updated

September 6, 2018

Record last verified: 2018-09

Locations